Periodic Reporting for period 4 - TARG-SUP (Targeting TGF-β activation, likely the core mechanism of immunosuppression by human regulatory T cells.)

Novel approaches for the treatment of cancer, collectively termed “cancer immunotherapies”, started to reach the clinic in 2011 and are yielding spectacular results, unfortunately only in a limited proportion of patients. Immunotherapeutic reagents aim at stimulating the...